David Rodman files Form 144 to sell 6,348 shares

David Rodman filed a Form 144 reporting proposed and recent sales of common stock.

Rhea-AI Filing Summary

David Rodman filed a Form 144 reporting proposed and recent sales of common stock. The notice lists a proposed sale of 6,348 shares tied to an exercise of employee stock options on 04/14/2025. The filing also records multiple completed sales between 01/09/2026 and 04/13/2026, including 14,058 shares sold on 04/13/2026 for $373,086.81.

Key Figures

Proposed shares to be sold: 6,348 shares Largest recorded sale in excerpt: 14,058 shares Example sale proceeds: $373,086.81 +1 more

4 metrics

Proposed shares to be sold 6,348 shares tied to exercise of employee stock options on 04/14/2025

Largest recorded sale in excerpt 14,058 shares sold on 04/13/2026 for $373,086.81

Example sale proceeds $373,086.81 proceeds from 14,058 shares on 04/13/2026

Other sample sale 6,348 shares sold on 01/12/2026 for $205,142.99

Key Terms

Form 144, exercise of employee stock options, proceeds

3 terms

Form 144 regulatory

"listed as a filing reporting proposed sale under Rule 144"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

exercise of employee stock options financial

"Exercise of employee stock options | Mineralys Therapeutics, Inc."

proceeds financial

"14,058 | 373086.81 appears as sale proceeds for a trade"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does David Rodman's Form 144 for MLYS report?

It reports a proposed sale of 6,348 shares tied to option exercise and multiple completed sales between 01/09/2026 and 04/13/2026. The filing lists trade dates, share counts, and sale proceeds for each transaction.

How many shares were proposed for sale under the Form 144?

The filing lists a proposed sale of 6,348 shares related to an exercise of employee stock options dated 04/14/2025. The transaction method is shown as cash in the notice.

What recent sales by Rodman are recorded in the filing?

The filing records multiple sales from 01/09/2026 through 04/13/2026, including notable entries of 14,058 shares sold on 04/13/2026 for $373,086.81 and other dated share/price lines.

Are the sales in the Form 144 open-market or related to option exercises?

The proposed sale of 6,348 shares is tied to an exercise of employee stock options. Other listed transactions show executed sales with dollar proceeds; specific sale methods beyond the option exercise are not detailed in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/15/2026 - 04:21 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001672659
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Mineralys Therapeutics, Inc.
SEC File Number	001-41614
Address of Issuer	150 N. RADNOR CHESTER RD. SUITE F200 RADNOR PENNSYLVANIA 19087
Phone	(888) 378-6240
Name of Person for Whose Account the Securities are To Be Sold	Rodman David Malcom
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock	Merrill Lynch 225 Liberty St Floor 37 New York NY 10281	6348	175585.68	82399478	04/15/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common stock	04/14/2025	Exercise of employee stock options	Mineralys Therapeutics, Inc.			6348	04/14/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common stock	01/09/2026	2170	72195.90
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common stock	01/12/2026	6348	205142.99
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common stock	01/13/2026	7709	252469.75
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common stock	01/14/2026	11367	370645.39
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	01/20/2026	416	13353.60
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	02/09/2026	2171	65585.91
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	02/12/2026	6349	184076.52
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	02/16/2026	14055	385732.29
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	02/17/2026	417	11505.03
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/09/2026	2171	58269.64
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/12/2026	6348	173748.15
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/13/2026	14058	369225.07
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	03/17/2026	417	10696.05
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/09/2026	2170	59414.60
David Rodman 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087	Common Stock	04/13/2026	14058	373086.81

144: Remarks and Signature

Remarks
Date of Notice	04/15/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	09/29/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	David Rodman
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)